enGene Statistics
Share Statistics
enGene has 51.19M
shares outstanding. The number of shares has increased by null%
in one year.
| 51.19M |
| n/a |
| n/a |
| 80.31% |
| n/a |
| 118 |
| 0.07% |
Short Selling Information
The latest short interest is 14.1K, so 0.03% of the outstanding
shares have been sold short.
| 14.1K |
| 0.03% |
| 0.03% |
| 1 |
Valuation Ratios
The PE ratio is -7.16 and the forward
PE ratio is -2.85.
enGene's PEG ratio is
0.11.
| -7.16 |
| -2.85 |
| 0 |
| 74.5 |
| 1.45 |
| -8.03 |
| 0.11 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for enGene.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 16.87,
with a Debt / Equity ratio of 0.09.
| 16.87 |
| 16.87 |
| 0.09 |
| -0.48 |
| -0.51 |
| 22.26 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-984.68K |
| 56 |
| 0 |
| n/a |
Taxes
| -19K |
| -0.03% |
Stock Price Statistics
The stock price has increased by 11.36% in the
last 52 weeks. The beta is -0.39, so enGene's
price volatility has been lower than the market average.
| -0.39 |
| 11.36% |
| 4.58 |
| 4.96 |
| 77.58 |
| 171,746 |
Income Statement
| n/a |
| -323K |
| 62.3M |
| -55.14M |
| -52.04M |
| -52.36M |
| -1.46 |
Full Income Statement Balance Sheet
The company has 173M in cash and 25.02M in
debt, giving a net cash position of 147.98M.
| 173M |
| 25.02M |
| 147.98M |
| -254.73M |
| 245.55M |
| 190.87M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -48.28M
and capital expenditures -925K, giving a free cash flow of -49.21M.
| -48.28M |
| -925K |
| -49.21M |
| -1.1 |
Full Cash Flow Statement Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |